Moreover, both the repression of Mmp9 and the activation of Prrg2 were easily recapitulated in Zbtb11 KO MEFs (Supplementary Fig. 9g), further confirming our previous results in cancer cells where MMP9 and PRRG2 are critical downstream targets of ZBTB11. Here, MMP9 is linked to cancer.